Promethazine Multi-System Effects and Toxic Dosing
Promethazine causes significant multi-organ system toxicity, with doses above 625 mg (approximately 10 mg/kg in a 60-kg adult) associated with a 42% probability of delirium, and the FDA-documented toxic range of 75-125 mg in children causing paradoxical hyperexcitability, while doses of 25-100 mg in adults can produce serious adverse effects across cardiovascular, respiratory, neurological, and local tissue systems. 1, 2
Organ System Effects
Central Nervous System
Promethazine acts as a phenothiazine with dopaminergic blockade and produces dose-dependent CNS effects 3, 4:
- Sedation and cognitive impairment: Therapeutic doses (25-50 mg) cause significant psychomotor impairment equivalent to blood alcohol levels of 0.085% for 25 mg and 0.137% for 50 mg 5
- Delirium: Occurs in 42% of overdose cases at median dose of 625 mg 2
- Extrapyramidal effects: Range from restlessness to oculogyric crises, dystonic reactions 3
- Neuroleptic malignant syndrome: Rare but life-threatening complication 3, 4
- Paradoxical reactions: In children, single doses of 75-125 mg cause hyperexcitability and nightmares 1
- Seizures: Rarely occur in overdose 1
Cardiovascular System
- Hypotension: Most common cardiovascular effect due to alpha-adrenergic blockade 3, 4
- Tachycardia: Heart rate >100 bpm occurs in 56% of overdose cases 2
- Requires slow IV infusion (≤25 mg/min) to minimize hypotension risk 3
Critical caveat: Epinephrine is contraindicated for promethazine-induced hypotension as it may paradoxically worsen hypotension due to partial adrenergic blockade; use norepinephrine or phenylephrine instead 1
Respiratory System
- Respiratory depression: Particularly when combined with opioids or benzodiazepines 3, 4
- Requires dose reduction of concurrent narcotics by 25-50% and benzodiazepines by at least 50% 3, 1
Anticholinergic Effects
Due to antimuscarinic properties 3, 4:
- Dry mouth
- Fixed, dilated pupils
- Flushing
- Urinary retention
- Gastrointestinal symptoms
Local Tissue Toxicity (Parenteral Administration)
FDA Black Box Warning for injectable form 1, 6:
- Tissue necrosis
- Gangrene
- Thrombophlebitis
- Severe tissue injury with inadvertent perivascular extravasation
- Catastrophic limb-threatening injury with intra-arterial injection
- Intraneuronal or perineuronal infiltration damage
Toxic Dose Levels for 60-kg Adult
Therapeutic Range
- Standard dose: 12.5-25 mg IV (slowly) or 25-50 mg total as adjuvant 3
- Maximum therapeutic: Up to 100 mg total dose has been used 4
Toxic Thresholds
Based on overdose data 2:
- 250 mg: 31% probability of delirium
- 500 mg: 42% probability of delirium
- 625 mg (median toxic dose): 42% delirium incidence in overdose series
- 1000 mg: 55% probability of delirium
Pediatric Toxic Doses
- 75-125 mg: Paradoxical hyperexcitability and nightmares in children 1
- Contraindicated in children <2 years due to respiratory depression risk 1
Overdose Clinical Presentation
Signs range from mild CNS depression to life-threatening toxicity 1:
Mild-Moderate:
- Drowsiness, sedation
- Hypotension
- Tachycardia
- Anticholinergic signs (dry mouth, mydriasis, flushing)
Severe:
- Profound hypotension
- Respiratory depression requiring ventilatory support
- Unconsciousness
- Delirium (most common serious effect at 42% incidence) 2
- Hyperreflexia, hypertonia, ataxia
- Extensor-plantar reflexes (Babinski sign)
- Convulsions (rare)
Notably absent: No seizures, dysrhythmias, or deaths reported in the 199-patient overdose series 2
Key Clinical Pitfalls
Combination with CNS depressants: Dramatically increases sedation and respiratory depression risk—mandates dose reduction of opioids by 25-50% 3, 1
Epinephrine contraindication: Will worsen hypotension; use norepinephrine or phenylephrine instead 1
IV administration technique: Must infuse slowly (≤25 mg/min) and ensure proper IV placement to avoid catastrophic tissue injury 3, 6
Psychomotor impairment: Even therapeutic doses cause significant cognitive impairment equivalent to legal intoxication 5
Charcoal benefit: Administration within 2 hours reduces delirium probability in predictable manner 2
Plasma half-life: 9-16 hours means prolonged effects and monitoring requirements 3, 4